Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Patient Focus

Sponsored by

Finalist

Transplant360

Astellas Pharma Europe in association with Choice Healthcare Solutions


Summary of work

The transplant360 programme demonstrates how the pharmaceutical industry can make a valuable contribution to patient health, aside from its product offerings. 

Patient focus directed every stage of the programme’s development and implementation, so that the solutions delivered support transplant patients directly and via their HCPs in a 360° approach. 

In 2011, the programme targeted adherence to immunosuppressant medication. Non-adherence is complex and was largely unacknowledged by HCPs, despite its catastrophic implications for organ transplant failure. Where non-adherence was recognised, HCPs had felt powerless to address it. 

Uptake of the programme across Europe has been impressive, exemplified by 80 per cent of UK transplant units adopting the programme and a more than 10-fold increase in visitors to the transplant360 website. 

The programme has also raised the profile of non-adherence as demonstrated by the leading international meeting agenda going from zero mentions of adherence, to widespread coverage between 2010 and 2012. Due to this programme, transplant patients are fully supported in maintaining their health and the health of their new organ. 

This highly targeted, patient support programme should become the template that others follow, in terms of its lack of commercial objectives, its patient focus and its powerful engagement of the whole clinical community.

 

 

Executive summary as submitted


COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics